Skip to content
Tenfell
Closed tender
Published 30 May 2017

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England

NHS England · London

Key facts

Estimated value
£710,890,000
Closing date
29 Jun 2017
Contract starts
31 Aug 2017
Contract ends
31 Aug 2019
Procedure
Open procedure
Buyer type
Central government

Description

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England

Offer reference number: CM/PHR/14/5446

Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months

CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months

Additional information: The procurement exercise is being conducted on the NHS England eTendering portal at www.nhsengland.bravosolution.co.uk the project code is tender_616 and the ITT code is itt_285. This is where the ITO documents are available.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.